Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impulse control disorders in Parkinson's disease.
Marques A, Durif F, Fernagut PO. Marques A, et al. Among authors: durif f. J Neural Transm (Vienna). 2018 Aug;125(8):1299-1312. doi: 10.1007/s00702-018-1870-8. Epub 2018 Mar 7. J Neural Transm (Vienna). 2018. PMID: 29511827 Review.
Body weight gain and deep brain stimulation.
Rieu I, Derost P, Ulla M, Marques A, Debilly B, De Chazeron I, Chéreau I, Lemaire JJ, Boirie Y, Llorca PM, Durif F. Rieu I, et al. Among authors: durif f. J Neurol Sci. 2011 Nov 15;310(1-2):267-70. doi: 10.1016/j.jns.2011.06.055. Epub 2011 Jul 18. J Neurol Sci. 2011. PMID: 21764406 Review.
Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease.
Bannier S, Berdagué JL, Rieu I, de Chazeron I, Marques A, Derost P, Ulla M, Llorca PM, Durif F. Bannier S, et al. Among authors: durif f. J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1019-21. doi: 10.1136/jnnp-2012-302414. Epub 2012 Jun 29. J Neurol Neurosurg Psychiatry. 2012. PMID: 22752694
The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease.
Mondillon L, Mermillod M, Musca SC, Rieu I, Vidal T, Chambres P, Auxiette C, Dalens H, Marie Coulangeon L, Jalenques I, Lemaire JJ, Ulla M, Derost P, Marques A, Durif F. Mondillon L, et al. Among authors: durif f. Neuropsychologia. 2012 Oct;50(12):2869-2879. doi: 10.1016/j.neuropsychologia.2012.08.016. Epub 2012 Aug 28. Neuropsychologia. 2012. PMID: 22944002 Clinical Trial.
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O; NS-Park CIC Network. Ory-Magne F, et al. Among authors: durif f. Neurology. 2014 Jan 28;82(4):300-7. doi: 10.1212/WNL.0000000000000050. Epub 2013 Dec 26. Neurology. 2014. PMID: 24371304 Clinical Trial.
276 results